Urinary Hydration Markers Tested for Storage Condition Validity
|
By LabMedica International staff writers Posted on 27 Aug 2019 |

Image: The 3320 osmometer used to assess urine osmolality, a measure of urine concentration and hydration (Photo courtesy of Advanced Instruments).
Fluid balance is an aspect of the homeostasis of organisms in which the amount of water in the organism needs to be controlled, via osmoregulation and behavior, such that the concentrations of electrolytes in the various body fluids are kept within healthy ranges.
The human kidneys will normally adjust to varying levels of water intake. The kidneys will require time to adjust to the new water intake level. This can cause someone who drinks a lot of water to become dehydrated more easily than someone who routinely drinks less. Analysis of urine specimens is widely utilized to determine day-to-day hydration status in individuals as well as for other markers of health.
Scientists at the University of North Carolina at Greensboro (Greensboro, NC, USA) enrolled eight males and 13 females (mean ± SD; age, 24 ± 5 years; body mass, 68.9 ± 24.2 kg; height, 160.2 ± 32.1 cm) without a history of renal disease or currently taking any medications or supplements known to affect the accuracy of urinary hydration markers. Participants provided a 24 hour urine sample in a clean container with each urine sample being separate into four separate containers, two in each of the following temperatures: 7 °C and 22 °C. One specimen container at each temperature was either sealed using the manufacturers cap (single sealed, SS) or the manufacturers cap plus laboratory wrapping film (double sealed, DS).
Each sample was analyzed after 1, 2, 3, 7 and 10 days. Urine samples were assessed for urine osmolality (UOSMO), urine specific gravity (USG), and urine color (UCOL). UOSMO was stable at 7 °C for two days and three days for single sealed and double sealed containers, respectively. UOSMO was determined via freezing point depression with a 3320 osmometer. USG was measured using an optical refractometer that was accurate to ±0.001 AU and had a resolution of 0.0001. UCOL was measured by comparing each urine sample to an 8-point urine color chart where the sample was held against a white background in a well-lit room.
The team reported that USG measures were stable for singled sealed and double sealed for up to ten days when stored at 22 °C. UCOL measures were maintained for up to three days in all storage methods. For refrigerated samples, UOSMO measures for samples stored in SS containers became significantly elevated three days following baseline measures, whereas UOSMO measures for samples stored in DS containers became significantly elevated seven days following baseline measures. Conversely to UOSMO, USG measures were significantly elevated in SS and DS samples stored at 7 °C beginning one day following baseline measures, compared to SS and DS samples stored at 20 °C.
The authors concluded that to achieve optimal results, it is recommended that 24-hour urine samples are assessed immediately for the respective hydration markers being analyzed. If immediate analysis is unavailable, such as in the case of field based or longitudinal research, it is recommended that 24-hour urine samples are stored in a refrigerated environment and hydration markers (UOSMO and UCOL) be assessed within 48 hours. The study was published on August 5, 2019, in the journal PLOS ONE.
Related Links:
University of North Carolina at Greensboro
The human kidneys will normally adjust to varying levels of water intake. The kidneys will require time to adjust to the new water intake level. This can cause someone who drinks a lot of water to become dehydrated more easily than someone who routinely drinks less. Analysis of urine specimens is widely utilized to determine day-to-day hydration status in individuals as well as for other markers of health.
Scientists at the University of North Carolina at Greensboro (Greensboro, NC, USA) enrolled eight males and 13 females (mean ± SD; age, 24 ± 5 years; body mass, 68.9 ± 24.2 kg; height, 160.2 ± 32.1 cm) without a history of renal disease or currently taking any medications or supplements known to affect the accuracy of urinary hydration markers. Participants provided a 24 hour urine sample in a clean container with each urine sample being separate into four separate containers, two in each of the following temperatures: 7 °C and 22 °C. One specimen container at each temperature was either sealed using the manufacturers cap (single sealed, SS) or the manufacturers cap plus laboratory wrapping film (double sealed, DS).
Each sample was analyzed after 1, 2, 3, 7 and 10 days. Urine samples were assessed for urine osmolality (UOSMO), urine specific gravity (USG), and urine color (UCOL). UOSMO was stable at 7 °C for two days and three days for single sealed and double sealed containers, respectively. UOSMO was determined via freezing point depression with a 3320 osmometer. USG was measured using an optical refractometer that was accurate to ±0.001 AU and had a resolution of 0.0001. UCOL was measured by comparing each urine sample to an 8-point urine color chart where the sample was held against a white background in a well-lit room.
The team reported that USG measures were stable for singled sealed and double sealed for up to ten days when stored at 22 °C. UCOL measures were maintained for up to three days in all storage methods. For refrigerated samples, UOSMO measures for samples stored in SS containers became significantly elevated three days following baseline measures, whereas UOSMO measures for samples stored in DS containers became significantly elevated seven days following baseline measures. Conversely to UOSMO, USG measures were significantly elevated in SS and DS samples stored at 7 °C beginning one day following baseline measures, compared to SS and DS samples stored at 20 °C.
The authors concluded that to achieve optimal results, it is recommended that 24-hour urine samples are assessed immediately for the respective hydration markers being analyzed. If immediate analysis is unavailable, such as in the case of field based or longitudinal research, it is recommended that 24-hour urine samples are stored in a refrigerated environment and hydration markers (UOSMO and UCOL) be assessed within 48 hours. The study was published on August 5, 2019, in the journal PLOS ONE.
Related Links:
University of North Carolina at Greensboro
Latest Technology News
- Robotic Technology Unveiled for Automated Diagnostic Blood Draws
- ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
- Aptamer Biosensor Technology to Transform Virus Detection
- AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
- AI-Generated Sensors Open New Paths for Early Cancer Detection
- Pioneering Blood Test Detects Lung Cancer Using Infrared Imaging
- AI Predicts Colorectal Cancer Survival Using Clinical and Molecular Features
- Diagnostic Chip Monitors Chemotherapy Effectiveness for Brain Cancer
- Machine Learning Models Diagnose ALS Earlier Through Blood Biomarkers
- Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Channels
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more






 Analyzer.jpg)
